AzTrials
AzTrials

Diaphragm Electrical ActivityNCT06163183

Does Diaphragm Electrical Activity Monitoring Predict Extubation Success in Children?

An observational study of Diaphragm Electrical Activity and Neurally Adjusted Ventilatory Assist, run by Mersin University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to record diaphragm electrical activity (Edi) during the preextubation (weaning) and postextubation periods and to analyze whether Edi monitoring could predict extubation success. Read more about this study

Who is it for?
Ages 2 months to 17 years
What is being tested?
Edi catheter
Type of treatment
Medical device
How many people
25 participants
Where
No sites listed yet
Study dates
1 Aug 2014to 30 Jul 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 months to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: The majority of the patients were under 18 months of age (median 18 months, between 2 and 204 months) and 60% (n=15) were female.

Who may be able to join

  • • Aged between one month and 18 years old
  • Intubated for more than 48 hours due to respiratory failure
  • Indication for the insertion of a nasogastric tube (Edi catheter), independent of the study
  • Ready for weaning:
  • Normal vital signs for age (fever, heart rate (HR), respiratory rate (RR), tension arterial (TA)
  • No catecholamines or sedation drugs
Show all 11Show fewer
  • pH of 7.35 to 7.45
  • Positive end expiratory pressure (PEEP) ≤6 mmHg
  • Fractionated oxygen (FiO2) ≤0.5
  • Oxygen saturation (SpO2) ≥92%
  • Vt≥ 5 ml/kg

Who cannot join

  • • Contraindication for the insertion of the nasogastric tube (Edi catheter)
  • Patients treated with muscle relaxants
  • Absence of consent given by the patient's family
  • Cases whose Edi levels could not be taken from ventilator's trend diagram due to missing values.

About this study

Official title: The Potential of Diaphragm Electrical Activity Monitoring to Predict Extubation Success in Children Requiring Mechanical Ventilation Support Due to Respiratory Failure

This study aimed to record diaphragm electrical activity (Edi) during the preextubation (weaning) and postextubation periods and to analyze whether Edi monitoring could predict extubation success.

Read the detailed description

This prospective observational study included 25 pediatric patients who were intubated due to respiratory failure in the pediatric intensive care unit of the tertiary university-affiliated Marmara University Hospital between August 2014 and July 2015. To conduct the study, we obtained informed consent from the patient's parents and ethical approval from the Marmara University Faculty of Medicine Scientific Research Ethics Committee Board on 06.09.2014. Pediatric patients included which had indication for the insertion of a nasogastric tube (Edi catheter), independent of the study. So Edi catheter had been used instead of nasogastric tube.

When the patients were ready for clinical weaning in accordance with the clinician, the Edi catheter was appropriately inserted into the patients. Then, a spontaneous breathing trial (SBT) was performed and diaphragm activity monitoring was recorded during this process. The patients who met the inclusion criteria switched in a spontaneous breath trial with pressure support ventilation (PSV) or NAVA (Neurally Adjusted Ventilatory Assist) on a Maquet (Solna, Sweden) Servo-i mechanical ventilator for both ventilation modes The patients' demographic and clinical characteristics, mortality scoring, vital parameters (HR, TA, SpO2, RR) and ventilatory parameters (Edi peak, Edi min, FiO2, expiratory Vt), as well as follow-up period were recorded. Arterial/capillary blood gases were taken within the last four hours before extubation and within the first, sixth, 12th, 18th and 24th hours after extubation. If arterial blood gas monitoring was initiated in the patient, arterial monitoring was continued. If capillary blood gas monitoring was initiated, capillary monitoring was continued. Edi data were recorded for at least 24 hours before and after extubation. Edi values were obtained retrospectively from the trend diagram, which provides 24-hour continuous records on the ventilator screen.

Being tested
Edi catheter
Keywords
pediatrics, extubation success, Diaphragm electrical activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Edi catheterDevice

Study groups in NCT06163183
Study groupRoleWhat they receive
Extubation failureNot described
Receives: Device: Edi catheter
Extubation successNot described
Receives: Device: Edi catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diaphragm electrical activity (Edi) monitoring

    Macquet (servo-i) mechanical ventilator measures the electrical activity (Edi) of the diaphragm (microvolts). Edi signals are measured using special feeding tubes (Edi catheter) equipped with tiny sensors at the level of gastroesophageal junction. In the ventilator, Edi trend values can be monitored continuously as 24-hour records.

    Measured: up to 2 days

  2. Mechanical ventilatory monitoring

    ventilatory parameters (Edi peak, Edi min, FiO2), were recorded during the follow up.

    Measured: up to 2 days

Secondary outcomes (3)
  1. Arterial/capillary blood gases

    If arterial blood gas monitoring was initiated in the patient, arterial monitoring was continued. If capillary blood gas monitoring was initiated, capillary monitoring was continued.

    Measured: Arterial/capillary blood gases were taken within the last four hours before extubation and within the first, sixth, 12th, 18th and 24th hours after extubation.

  2. Vital signs ((fever, heart rate (HR), respiratory rate (RR), tension arterial))

    Vital signs recorded by pediatric intensive care nurses.

    Measured: up to 2 days

  3. Expiratory tidal volume

    Patients who had >5ml/kg expiratory tidal volume considered to be ready for extubation

    Measured: From spontaneous breathing trial until the time for extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2023
  2. Study start1 Aug 2014
  3. Primary completion30 Jul 2015
  4. Study completion30 Jul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06163183
Sponsor's protocol ID
1400124188
Status last verified
Dec 2023
First submitted
27 Nov 2023
Last updated
8 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected IPD, will be shared in publication study

Publications

  • Beck J, Sinderby C. Neurally Adjusted Ventilatory Assist in Newborns. Clin Perinatol. 2021 Dec;48(4):783-811. doi: 10.1016/j.clp.2021.07.007. Epub 2021 Oct 2.

    PubMed 34774209

Questions about this trial

What is this clinical trial studying?

An observational study of Diaphragm Electrical Activity and Neurally Adjusted Ventilatory Assist, run by Mersin University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diaphragm electrical activity (Edi) monitoring (time frame: up to 2 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06163183, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in